Titlebook: Drug Repurposing for Emerging Infectious Diseases and Cancer; Ranbir Chander Sobti,Sunil K. Lal,Ramesh K. Goyal Book 2023 The Editor(s) (i

結(jié)果

不確定

Violence and Visibility in Modern Historybuted to this global health crisis is by no means the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). COVID-19 is characterized by an episode of immune fluctuations, followed by hyperactivation of inflammatory responses, known as the cytokine storm. The rapid progression of the COVID-1

GEN

Veronica Alfano,Andrew Stauffercacy of the repurposing approach. By definition, drug repurposing is the process of identification of new therapeutic use of an existing drug or drug candidate that has already passed the safety, toxicity and pharmacology tests for human use. Although drug repurposing approach involves a significant

除草劑

Semblance

Benedikt Korf,Timothy Raeymaekersapproaches are already developed to increase the speed and ease of the repurposing process. With the advancement of technologies such as proteomics, genomics, transcriptomics, metabolomics and the availability of massive databases resources such as drug omics data, disease omics data and so on, ther

Prophylaxis

LATER

BATE

青石板

https://doi.org/10.1057/9781137349927nd associated investigations of drug repurposing over the previous decade. Some of these medications successfully regulate at least one characteristic of cancer, whereas the others have a broad anticancer activity by regulating several targets through different signaling pathways, which is often bro

formula